Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report

• Main Authors: Camille Verocq (Author), Marie-Lucie Racu (Author), Dominique Bafort (Author), Gloria Butorano (Author), Luis Perez-Casanova Garcia (Author), Julie Navez (Author), Marc Witterwulghe (Author), Kieran Sheahan (Author), Niall Swan (Author), Jean Closset (Author), Jean-Luc Van Laethem (Author), Calliope Maris (Author), Nicky D'Haene (Author)
• Format: Book
• Published: BMC, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Pancreatic medullary carcinoma (PMC) is a rare pancreatic tumor, usually showing the presence of microsatellite instability, mostly MLH1 silencing, and a wild-type KRAS mutation status. We report here a PMC arising from a Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN),...